Drug development under the eye of the U.S. Food & Drug Administration (FDA) is a notoriously long and fraught process, spanning an average of 11 years where only 8% of proposed products reach approval. Aware of the limitations this presents for both physicians and patients, the FDA recognizes four programs aimed at facilitating and expediting the develo…
© 2024 Bohdan (Bo) Khomtchouk, Ph.D.
Substack is the home for great culture